CONTEXT: Investigation of activin-A (A) and myostatin (M) in human myometrium (HM) and leiomyoma (HL) will explain their involvement in human myometrial pathophysiology. OBJECTIVE: We aimed to investigate A and M response and steroid regulation in HM. We also evaluated A and M expression and response in HL. DESIGN: Tissues were analyzed and cultured. PATIENTS: Patients included fertile (in proliferative phase) and menopausal women undergoing hysterectomy. INTERVENTIONS: HM explant cultures were treated with A and M (for Smad-7 mRNA quantification) or estrogen and progesterone (for A and M mRNA quantification). A and M expression levels were also evaluated in menopausal (physiological absence of steroids) HM specimens. A and M and their receptors were evaluated in HL (n = 8, diameter 5-8 cm) compared with their matched HM. HL explants cultures were treated with A and M (for Smad7 mRNA quantification), and, to explain the absence of response, the levels of follistatin, follistatin-related gene (FLRG), and Cripto were evaluated. RESULTS: A and M increased Smad7 expression in HM explants. A and M mRNAs were both reduced after estradiol treatment, unchanged after progesterone treatment, but were higher in menopausal than fertile (in proliferative phase) specimens. A, M, and FLRG were expressed at higher levels in HL compared with adjacent HM, whereas the receptors, follistatin, and Smad7 mRNAs resulted unchanged. Cripto mRNA was expressed only in HL. CONCLUSIONS: A and M act on human HM and are regulated by steroids. In HL there is an increase of A, M, FLRG, and Cripto expression.
CONTEXT: Investigation of activin-A (A) and myostatin (M) in human myometrium (HM) and leiomyoma (HL) will explain their involvement in human myometrial pathophysiology. OBJECTIVE: We aimed to investigate A and M response and steroid regulation in HM. We also evaluated A and M expression and response in HL. DESIGN: Tissues were analyzed and cultured. PATIENTS: Patients included fertile (in proliferative phase) and menopausal women undergoing hysterectomy. INTERVENTIONS: HM explant cultures were treated with A and M (for Smad-7 mRNA quantification) or estrogen and progesterone (for A and M mRNA quantification). A and M expression levels were also evaluated in menopausal (physiological absence of steroids) HM specimens. A and M and their receptors were evaluated in HL (n = 8, diameter 5-8 cm) compared with their matched HM. HL explants cultures were treated with A and M (for Smad7 mRNA quantification), and, to explain the absence of response, the levels of follistatin, follistatin-related gene (FLRG), and Cripto were evaluated. RESULTS: A and M increased Smad7 expression in HM explants. A and M mRNAs were both reduced after estradiol treatment, unchanged after progesterone treatment, but were higher in menopausal than fertile (in proliferative phase) specimens. A, M, and FLRG were expressed at higher levels in HL compared with adjacent HM, whereas the receptors, follistatin, and Smad7 mRNAs resulted unchanged. Cripto mRNA was expressed only in HL. CONCLUSIONS: A and M act on human HM and are regulated by steroids. In HL there is an increase of A, M, FLRG, and Cripto expression.
Authors: D S Saloman; C Bianco; A D Ebert; N I Khan; M De Santis; N Normanno; C Wechselberger; M Seno; K Williams; M Sanicola; S Foley; W J Gullick; G Persico Journal: Endocr Relat Cancer Date: 2000-12 Impact factor: 5.678
Authors: Nicholas J Laping; Jeffrey I Everitt; Kendall S Frazier; Mark Burgert; Melisa J Portis; Caprice Cadacio; Leslie I Gold; Cheryl L Walker Journal: Clin Cancer Res Date: 2007-05-15 Impact factor: 12.531
Authors: Jennifer J Hill; Monique V Davies; Adele A Pearson; Jack H Wang; Rodney M Hewick; Neil M Wolfman; Yongchang Qiu Journal: J Biol Chem Date: 2002-08-22 Impact factor: 5.157
Authors: Enrrico Bloise; Henrique L Couto; Lauretta Massai; Pasquapina Ciarmela; Marzia Mencarelli; Lavinia E Borges; Michela Muscettola; Giovanni Grasso; Vania F Amaral; Geovanni D Cassali; Felice Petraglia; Fernando M Reis Journal: BMC Cancer Date: 2009-09-09 Impact factor: 4.430
Authors: Md Soriful Islam; William H Catherino; Olga Protic; Milijana Janjusevic; Peter Clarke Gray; Stefano Raffaele Giannubilo; Andrea Ciavattini; Pasquale Lamanna; Andrea Luigi Tranquilli; Felice Petraglia; Mario Castellucci; Pasquapina Ciarmela Journal: J Clin Endocrinol Metab Date: 2014-02-25 Impact factor: 5.958
Authors: Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy Journal: Am J Pathol Date: 2018-08-01 Impact factor: 4.307
Authors: Joshua B Benoit; Geoffrey M Attardo; Veronika Michalkova; Tyler B Krause; Jana Bohova; Qirui Zhang; Aaron A Baumann; Paul O Mireji; Peter Takáč; David L Denlinger; Jose M Ribeiro; Serap Aksoy Journal: PLoS Genet Date: 2014-04-24 Impact factor: 5.917
Authors: Md Soriful Islam; Sadia Afrin; Bhuchitra Singh; Friederike L Jayes; Joshua T Brennan; Mostafa A Borahay; Phyllis C Leppert; James H Segars Journal: Clin Transl Med Date: 2021-07
Authors: Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela Journal: Obstet Gynecol Int Date: 2013-09-12